Priority Healthcare Receives Subpoena from the Department of Justice
16 November 2004 - 11:30AM
PR Newswire (US)
Priority Healthcare Receives Subpoena from the Department of
Justice LAKE MARY, Fla., Nov. 15 /PRNewswire-FirstCall/ -- Priority
Healthcare Corporation (NASDAQ:PHCC) announced that it received a
subpoena from the U.S. Department of Justice(DOJ) requiring the
company to provide the DOJ with certain information regarding the
promotion and marketing of Actimmune, a product manufactured by
InterMune, Inc. The company believes that the materials sought by
the DOJ are part of an ongoing investigation being conducted by the
United States Attorney's Office for the Northern District of
California. The company intends to fully cooperate with the
Department of Justice. About Priority Healthcare Corporation
Priority Healthcare Corporation is a national specialty pharmacy
and distributor that provides biopharmaceuticals, complex
therapies, and related disease treatment services. Priority
Healthcare provides comprehensive programs for patients, payors,
physicians, and pharmaceutical manufacturers for a growing number
of disease states, including cancer, hepatitis C, respiratory and
pulmonary conditions, infertility, rheumatoid arthritis,
hemophilia, multiple sclerosis, Parkinson's disease, and macular
degeneration. Additional information regarding Priority Healthcare
is available online at http://www.priorityhealthcare.com/. Certain
statements included in this press release, which are not historical
facts, are forward-looking statements. Such forward-looking
statements are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. These
forward-looking statements represent our expectations or beliefs
and involve certain risks and uncertainties, including those
described in our public filings with the United States Securities
and Exchange Commission; also including, but not limited to,
changes in interest rates, competitive pressures, changes in
customer mix, changes in third party reimbursement rates, financial
stability of major customers, changes in government regulations or
the interpretation of these regulations, changes in supplier
relationships, growth opportunities, cost savings, revenue
enhancements, synergies and other benefits anticipated from
acquisition transactions, difficulties relative to integrating
acquired businesses, the accounting and tax treatment of
acquisitions, and asserted and unasserted claims, which could cause
actual results to differ from those in the forward-looking
statements. The forward-looking statements by their nature involve
substantial risks and uncertainties, certain of which are beyond
our control, and actual results may differ materially depending on
a variety of important factors. You are cautioned not to place
undue reliance on these forward-looking statements that speak only
as of the date herein.
http://www.newscom.com/cgi-bin/prnh/20030417/PHCLOGO
http://photoarchive.ap.org/ DATASOURCE: Priority Healthcare
Corporation CONTACT: Stephen Saft, Chief Financial Officer,
Priority Healthcare Corporation, +1-407-804-6700 Web site:
http://www.priorityhealthcare.com/
Copyright
Priority Healthcare b (NASDAQ:PHCC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Priority Healthcare b (NASDAQ:PHCC)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Priority Healthcare b (MM) (NASDAQ): 0 recent articles
More Priority Healthcare Corp (MM) News Articles